Fundraising Fox
/Companies
Sign in

Nanoviricides

NYSE: NNVC

Shelton, US · Delaware corporation

Find your way into Nanoviricides

Each arrow is one introduction. Sign up to fill in the first one.

306 people can intro you to Meeta

Ask Jonathan Huberman to introduce you to Meeta Vyas

You →Jonathan · together at The Gores Group →Meeta

28 people can intro you to Anil

Ask Jamie Chen to introduce you to Anil Diwan

You →Jamie · together at Rice University →Anil

Sign up to find every way you can get introduced to Nanoviricides

  • Your email: who you already know at Nanoviricides, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nanoviricides team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

NanoViricides develops antiviral drugs using nanomedicine technology designed to directly attack and destroy virus particles by mimicking host cell surface features that viruses use for infection. The company's platform approach targets multiple viral families including coronavirus, herpes, HIV, and influenza through a mechanism intended to prevent viral resistance, with its lead candidate in Phase II clinical development.

BiotechHealthtech

Founders & leadership

ADAnil Diwan
Anil DiwanPresident, Chairman and Chief Executive OfficerAnil Diwan is President, Chairman and CEO of NanoViricides, which he co-founded in 2005 to develop antiviral nanomedicines. He holds a Ph.D. from Rice University and a B.Tech. from IIT Mumbai, with over 35 years in biopharmaceutical R&D and prior experience co-founding TheraCour Pharma and AllExcel.
MVMeeta Vyas
Meeta VyasExecutiveMeeta Vyas holds a BS in Chemical Engineering from MIT and an MBA in Finance from Columbia University. She has served as CFO and operating partner at private equity firms including The Gores Group and Kamylon Capital, as well as CEO of Signature Brands, a portfolio company of Thomas H Lee Partners, before joining NanoViricides as Executive Officer.

Board

TE
Theodore Edward RokitaBoard director
ZB
Zucker BrianBoard director
MJ
Makarand JawadekarBoard director
MK
Mukund KulkarniIndependent Director
MB
Milton BoniukIndependent Director
SG
Stanley GlickIndependent Director

Reported raises · per SEC filings

Form D private placements

$8.5M disclosed across 2 rounds · 2019–2025

▶$6MraisedFeb 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Meeta VyasExecutive Officer
  • Theodore Edward RokitaDirector
  • Zucker BrianDirector
  • Anil DiwanExecutive Officer, Director
  • Makarand JawadekarDirector
Offering amount
$6M
Amount sold
$6M
Sales commissions
$420K
Placement agents
A.G.P. / Alliance Global Partners
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedMar 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Anil DiwanExecutive Officer, Director
  • Mukund KulkarniDirector
  • Milton BoniukDirector
  • Meeta VyasExecutive Officer
  • Stanley GlickDirector
Offering amount
$2.5M
Amount sold
$2.5M
Minimum investment
$1.3M
Finders' fees
$125K
Placement agents
Chardan Capital Markets, LLC
First sale
Feb 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Nanoviricides do?
NanoViricides develops antiviral drugs using nanomedicine technology designed to directly attack and destroy virus particles by mimicking host cell surface features that viruses use for infection. The company's platform approach targets multiple viral families including coronavirus, herpes, HIV, and influenza through a mechanism intended to prevent viral resistance, with its lead candidate in Phase II clinical development.
Who founded Nanoviricides?
Nanoviricides was founded by Anil Diwan.
How much funding has Nanoviricides raised?
Nanoviricides has disclosed $8.5M raised across 2 rounds.
Where is Nanoviricides headquartered?
Nanoviricides is headquartered in Shelton, US.